Hints and tips:
Related Special Reports
...Several of the world’s biggest pharmaceutical companies are fighting shareholder proposals to force them to disclose information on their use of a controversial patent strategy that can delay rivals from...
...the market, raising overall health service costs....
...While politicians on both sides of the aisle believe drug prices in the world’s largest pharmaceutical market need to be cut, they disagree on how to do it....
...Other repurposed generic drugs may prove better value....
...The CMA said the NHS had “no choice” but to pay “unfairly high prices” for the drug, which cost the health service £50m in 2013, up from just £2m the previous year....
...The service is launching this week to customers in 45 US states to users over the age of 18....
...generic drugmaker based just outside Tel Aviv....
...In these areas companies are expected to prosper from the acceleration of digital services spurred by shutdowns, homeworking and social distancing....
...The European Commission is in talks with Gilead Sciences, the US pharmaceuticals company, to reserve doses of the drug remdesivir to combat coronavirus after Washington announced that it had bought up much...
...Prices in Europe are typically much lower than in the US, partly because national health services can negotiate bulk discounts with manufacturers....
...West Pharmaceutical Services Sector: pharmaceuticals / HQ: Exton, PA, US The almost 100-year-old medical supplies company is a specialist in the equipment that so many Covid-19 drug and vaccine makers...
...Their promises to accept more manufacturing and services imports from the US are even more ambitious....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...The Federal Trade Commission is already looking into competition in the pharmaceutical supply chain....
...Like other US drugstore chains, Walgreens’ margins are being hit by pressure to cut prescription drug prices as well as cheaper generic drugs....
...But Starboard will withdraw its proxy solicitation after Institutional Shareholder Services and Glass Lewis gave their blessings on Friday to a transaction that would create one of the world’s largest producers...
...Spending on pharmaceutical drugs is forecast to rise an average of 6.3 per cent a year from 2017 to 2026, according to the US government’s Center for Medicare and Medicaid Services....
...In November, Keytruda was approved for use in the UK’s National Health Service....
...names in the pharmaceuticals industry to secure a slice of a near $20bn global market....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...The pharmaceuticals industry was a big beneficiary of the president's recent tax changes. Here’s our guide to drug pricing....
...Among local star performers is Incepta Pharmaceuticals, Bangladesh’s second-largest generics maker, which exports to about 60 countries, and Popular Pharmaceuticals, which is eyeing an eventual listing....
...Last year saw the approval of 39 imported drugs, more than in the previous three years combined, according to industry data service GBI Health....
...This has allowed the city to operate at a scale that is rare in the National Health Service....
...In the last financial year, it has saved £170m through the use of three biosimilars — well on the way to a goal set by Simon Stevens, head of the health service in England, to save £300m from this approach...
International Edition